Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1252607-54-7

1252607-54-7

Post Buying Request

1252607-54-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1252607-54-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1252607-54-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,2,6,0 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1252607-54:
(9*1)+(8*2)+(7*5)+(6*2)+(5*6)+(4*0)+(3*7)+(2*5)+(1*4)=137
137 % 10 = 7
So 1252607-54-7 is a valid CAS Registry Number.

1252607-54-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(1,3-Benzodioxol-5-yloxy)cyclohexanone

1.2 Other means of identification

Product number -
Other names 4-[1,3-benzodioxol-5-yl(hydroxy)methyl]-3-(3,4,5-trimethoxybenzyl)dihydrofuran-2(3h)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1252607-54-7 SDS

1252607-54-7Upstream product

1252607-54-7Downstream Products

1252607-54-7Relevant articles and documents

4-AZETIDINYL-1-HETEROATOM LINKED-CYCLOHEXANE ANTAGONISTS OF CCR2

-

Page/Page column 45, (2010/11/03)

The present invention comprises compounds of Formula (I). wherein: X, R1, R2, R3, and R4 are as defined in the specification. The invention also comprises a method of preventing, treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is type II diabetes, obesity and asthma. The invention also comprises a method of inhibiting CCR2 activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula (I).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1252607-54-7